Atherosclerosis is an immune inflammatory disease and a major cause of mortality and morbidity worldwide. It is generally considered that a number of potent proinflammatory
cytokines have a great influence on its pathogenesis, including IL-1β,
IL-6, TNF-α, and NF-κB. A growing amount of empirical evidence indicates that the mechanism of cardiac dysfunction caused by
lipopolysaccharide (LPS) is the activation of
inflammation, but the exact mechanism in
atherosclerosis is still unclear. Previous studies have shown that
interferon-induced
protein with tetratricopeptide repeats 1 (IFIT1) participates in
inflammation, but the effects and possible mechanism of action of IFIT1 on proinflammatory response remain largely unexplained. We found that LPS induced upregulation of IFIT1 expression in a time- and concentration-dependent manner in human umbilical vein endothelial cells (HUVECs). Overexpression of IFIT1 significantly upregulated LPS-induced expression of IL-1β,
IL-6, TNF-α, and NF-κB in HUVECs. IFIT1-siRNA treatment dramatically decreased LPS-induced expression of IL-1β,
IL-6, TNF-α, and NF-κB in HUVECs. The above results show that LPS induces expression of IL-1β,
IL-6, TNF-α, and NF-κB through upregulating IFIT1 expression in HUVECs, and suggested that IFIT1 could act as potential therapeutic target to ameliorate
atherosclerosis-related diseases.